Confo Therapeutics

Confo Therapeutics is rated 3 out of 5 in the category biotechnology. Read and write reviews about Confo Therapeutics. Confo Therapeutics is an emerging drug discovery company built around a disruptive technology to enable the discovery of GPCR agonists. The CONFO® technology uses single domain antibodies to lock inherently unstable GPCRs in the druggable conformation and uses this stabilized complex as a superior starting point for GPCR drug discovery. The company's strategy is to broadly exploit its technology by building a unique portfolio of therapeutic programs in various disease areas, both for its own pipeline as well as with pharma partners. For more information: www.confotherapeutics.com